To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

June 3, 2022

Join us at ASCO 2022 June 3rd - 7th - Booth #3005

EBCI and ASCO meeting poster

ASCO booth poster

ASCO logo

The ASCO Annual Meeting is for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide. You can Instantly access the top oncology research from ASCO meetings—including abstracts, videos, posters, and slides.

EBCI will, once again, be attending this amazing event in order to continue our mission to increase access to treatment options through creating disease education/awareness & outreach partnerships with other top oncology companies. We will also be doing a special introduction of our NEW & EXCITING EBCI APP (available for iPhone and Android.)

Why an App?

Our goal is to expand and accelerate the flow of vital disease education information on advanced treatments, diagnostics, clinical trials, and more into the hands and minds of those diagnosed with brain cancer, brain tumors, or metastasized disease to the brain, their caregivers, and their medical teams.


Clinical Trial Information, Patient Resources, Research Articles, Meetings & Events & More!

It's FREE!

The app is 100% free due to corporate sponsorship and disease education grants. It works on both iPhone and Android and can be safely downloaded via the QR Code on the front of this card. 

Get Involved!

Contact Shawn at to discuss sponsorship and/or disease education grant opportunities. Get your logo and your information out in front of our audience! Curated and Branded channels are available and a great way to introduce your company, products, and any Calls to Action related to access, coverage, policy change, etc.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram